Financial Ratios

WANBURY LTD.

NSE : WANBURYBSE : 524212ISIN CODE : INE107F01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE276.90-6.1 (-2.16 %)
PREV CLOSE ( ) 283.00
OPEN PRICE ( ) 284.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5059
TODAY'S LOW / HIGH ( )274.00 284.90
52 WK LOW / HIGH ( )151.1 330
NSE277.35-3.75 (-1.33 %)
PREV CLOSE( ) 281.10
OPEN PRICE ( ) 284.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 277.35 (42)
VOLUME 36814
TODAY'S LOW / HIGH( ) 270.60 284.90
52 WK LOW / HIGH ( )153.37 329.7
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)9.28-3.1824.94-5.0425.79
   CEPS(Rs)13.260.6128.45-1.1429.66
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)6.44-2.750.29-52.37-47.23
   Tax Rate(%)1.24-1.06-0.43-1.610.32
Margin Ratios
   Core EBITDA Margin(%)12.054.536.173.97-5.83
   EBIT Margin(%)10.322.1819.772.7126.30
   Pre Tax Margin(%)5.30-2.0215.77-3.1517.44
   PAT Margin (%)5.23-2.0415.83-3.2017.38
   Cash Profit Margin (%)7.480.3918.06-0.7219.99
Performance Ratios
   ROA(%)9.58-3.2425.97-4.5423.23
   ROE(%)502.760.000.000.000.00
   ROCE(%)61.6117.68206.2628.24204.91
   Asset Turnover(x)1.831.591.641.421.34
   Sales/Fixed Asset(x)2.382.182.321.881.83
   Working Capital/Sales(x)-10.60-2.95-3.16-1.70-1.93
Efficiency Ratios
   Fixed Capital/Sales(x)0.420.460.430.530.55
   Receivable days49.7847.2334.5039.4546.85
   Inventory Days18.2325.7026.4517.1715.54
   Payable days187.52196.83189.83209.99242.15
Valuation Parameters
   PER(x)15.710.003.410.000.71
   PCE(x)11.0061.382.99-72.770.61
   Price/Book(x)22.63-13.55296.26-1.58-0.39
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.010.360.620.910.52
   EV/Core EBITDA(x)7.977.578.6717.447.83
   EV/EBIT(x)9.7016.413.1433.391.97
   EV/CE(x)4.223.210.921.260.70
   M Cap / Sales0.830.240.540.530.12
Growth Ratio
   Net Sales Growth(%)15.21-2.2630.236.82-6.11
   Core EBITDA Growth(%)203.06-34.5980.29-16.93-1.14
   EBIT Growth(%)439.86-89.08853.58-89.06554.70
   PAT Growth(%)392.42-112.76746.33-119.56359.41
   EPS Growth(%)392.07-112.74594.95-119.54346.18
Financial Stability Ratios
   Total Debt/Equity(x)5.21-7.1271.51-1.22-1.39
   Current Ratio(x)0.740.410.510.290.32
   Quick Ratio(x)0.580.340.360.220.28
   Interest Cover(x)2.050.524.940.462.97
   Total Debt/Mcap(x)0.230.530.240.773.60

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.